Evidence map›Paper›PMID 34331184›Full record

ArticleFamilial cancer2023

Unusual phenotypes in patients with a pathogenic germline variant in DICER1.

Kateryna Venger, Miriam Elbracht, Julia Carlens, Peter Deutz, Felix Zeppernick, Lisa Lassay, Christian Kratz, Martin Zenker, Jung Kim, Douglas R Stewart and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Familial cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Kateryna VengerDivision of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, Medical Faculty, RWTH Aachen University, Aachen, Germany.
Miriam ElbrachtInstitute of Human Genetics, Medical Faculty, RWTH Aachen University, Aachen, Germany.
Julia CarlensClinic for Pediatric Pulmonology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany.
Peter DeutzDivision of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, Medical Faculty, RWTH Aachen University, Aachen, Germany.
Felix ZeppernickDepartment of Gynecology and Obstetrics, Medical Faculty, RWTH Aachen University, Aachen, Germany.
Lisa LassayDivision of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, Medical Faculty, RWTH Aachen University, Aachen, Germany.
Christian KratzClinic for Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.
Martin ZenkerInstitute of Human Genetics, University Hospital Magdeburg, Magdeburg, Germany.
Jung KimDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD, USA.
Douglas R StewartDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD, USA.
Ilse WielandInstitute of Human Genetics, University Hospital Magdeburg, Magdeburg, Germany.
Kris Ann P SchultzInternational PPB/DICER1 Registry, Minneapolis, MN, USA.
Nicolaus SchwerkClinic for Pediatric Pulmonology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany.
Ingo KurthInstitute of Human Genetics, Medical Faculty, RWTH Aachen University, Aachen, Germany.
Udo KontnyDivision of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, Medical Faculty, RWTH Aachen University, Aachen, Germany. ukontny@ukaachen.de.ORCID 0000-0002-3072-6772
RWTH Aachen University · DEMedizinische Hochschule Hannover · DENational Cancer Institute · USUniversity Hospital Magdeburg · DEChildren's Minnesota · USUniversitätsklinikum Gießen und Marburg · DE

Funding

Detecting DICER1: A global partnership to cure pediatric lung cancerR37CA244940 · NCI · CHILDREN'S HOSPITALS AND CLINICS · PI Kris Ann Pinekenstein Schultz · 2020 to 2026
$2.4M
NCI NIH HHS R37 CA244940
6 · The paper itself

Abstract

Pathogenic germline DICER1 variants are associated with pleuropulmonary blastoma, multinodular goiter, embryonal rhabdomyosarcoma and other tumour types, while mosaic missense DICER1 variants in the RNase IIIb domain are linked to cause GLOW (global developmental delay, lung cysts, overgrowth, and Wilms' tumor) syndrome. Here, we report four families with germline DICER1 pathogenic variants in which one member in each family had a more complex phenotype, including skeletal findings, facial dysmorphism and developmental abnormalities. The developmental features occur with a variable expressivity and incomplete penetrance as also described for the neoplastic and dysplastic lesions associated with DICER1 variants. Whole exome sequencing (WES) was performed on all four cases and revealed no further pathogenic or likely pathogenic dominant, homozygous or compound heterozygous variants in three of them. Notably, a frameshift variant in ARID1B was detected in one patient explaining part of her phenotype. This series of patients shows that pathogenic DICER1 variants may be associated with a broader phenotypic spectrum than initially assumed, including predisposition to different tumours, skeletal findings, dysmorphism and developmental abnormalities, but genetic work up in syndromic patients should be comprehensive in order not to miss additional underlying /modifying causes.

Indexed as

CystsGerm-Line MutationDEAD-box RNA HelicasesFemaleFrameshift MutationGerm CellsHumansPhenotypeRibonuclease IIIDEAD-box RNA HelicasesDICER1 protein, humanRibonuclease IIIDevelopmental delayDICER1Pierre-Robin sequenceSkeletal findingsUnusual phenotype

Identifiers

PMID34331184
PMCPMC9743360
OpenAlexW3183438171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.